ZC3H12A (CT) Peptide | 9547P

ZC3H12A (CT) Peptide | 9547P | Gentaur UK, US & Europe Distribution

Product Type: Peptides

Research Area: N/A

Host Species: N/A

Species Reactivity: N/A

Homology: N/A

Immunogen: N/A

Tested Application: Bl

Predicted MW: N/A

Purification: N/A

Clonality: N/A

Clone: N/A

Isotype: N/A

Conjugate: N/A

Physical State: Liquid

Buffer: PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide

Concentration: 200 ug/mL

Storage: Store SARS-CoV-2 (COVID-19) Spike Q493R G496S Q498R N501Y Y505H Peptide (Omicron) at -20˚C, stable for one year.

Additional Names: ZC3H12A Antibody: Endoribonuclease ZC3H12A, Monocyte chemotactic protein-induced protein 1, MCP-induced protein 1, MCPIP-1, Zinc finger CCCH domain-containing protein 12A

Background: ZC3H12A Antibody: ZC3H12A is an MCP1 (CCL2; MIM 158105) -induced protein that acts as a transcriptional activator and causes cell death of cardiomyocytes, possibly via induction of genes associated with apoptosis. ZC3H12A inhibits the Wnt/beta-catenin signaling pathway activity and modulates epithelial-mesenchymal transition during clear cell renal cell carcinoma progression by targeting miRNAs. ZC3H12A ribonuclease can bind and cleave AURKA mRNA in MYCN-amplified neuroblastoma cells. ZC3H12A is a novel link between diabetogenic conditions and impaired insulin secretory capacity. ZC3H12A overexpression in human neuroblastoma cell lines causes cell-cycle arrest by G1/S checkpoint block.

Shipping Condition: Blue Ice

Source: N/A

Species: Human

Peptide Location: 14 amino acids near the carboxyl terminus of human ZC3H12A.

By Source: N/A

By Species: N/A

Recombinant Protein Sequence: N/A

Badges: N/A